Changes to Att 5 - Clinician Post-Intervention Cover Letter

Post Clinician Survey-First Mailing [Flesch-Kincaid Reading Level 11.9]

MCO Letterhead

HFHS or ABQ HP/Lovelace Letterhead

Date

Clinician name

Address 1

Address 2

City State Zip

Dear [Clinician’s name]:

The Centers for Disease Control and Prevention (CDC) asked [MCO] and Battelle Centers for Public Health Research to conduct a research study to test methods to increase colorectal cancer (CRC) screening. Study results will tell us what works to increase CRC screening, and will help [MCO] and the CDC to improve clinical training and patient education materials concerning CRC screening.

We began this study approximately one year ago, and implemented a randomized controlled trial to test the effects of patient- and clinic-focused interventions on CRC screening. Nearly all Most primary care clinics at [MCO] are participating in this study.

The survey includes questions about your background, your preventive services opinions, and your colorectal cancer screening training, experience, practices, and opinions.

We need the response of every clinician in our sample to make this important study valid and influential. Your experience and opinions are essential to this study. This survey will take approximately 15 to 45 30 minutes to complete. We realize your time is valuable, so we have enclosed $50 as a reimbursement for your time and effort.

Your responses will be compiled with those of other clinicians in the study, and your responses will private. Your name will not appear with the survey. No individual will be identified in the any papers or reports and all study findings will be presented in the aggregate.

Of course, completing this survey is completely voluntary, and you may choose to stop at any time or to answer only some of the questions. If you choose not to complete this survey, this will not have any adverse consequences for you, your practice, or your patients. Some questions about your provision of advice to patients, or about your practices that may differ from institutional clinical practice recommendations may cause you discomfort. The results of this study, however, will provide critical information for the CDC and [MCO] to improve methods to increase CRC screening rates. Your returning this survey provides your consent to participate.

Your completed survey should be sent directly to Battelle Please return your survey in the envelope provided. If you have any questions about this research study, please call [Battelle contact] at Battelle, at (206) 528-xxxx or [MCO contact] at [MCO], at (xxx) xxx-xxxx. If you have questions about your rights as a research participant, you may call Battelle’s human subjects supervisor, Margaret Pennybacker, PhD, toll free, at 1-877-810-9530, extension 500. [Insert Appropriate MCO Contact Information and IRB Information, as needed].

We hope you will help us with this important study. Thank you for taking the time to complete this survey.

Sincerely,

MCO contact] Daniel Montaño, PhD

[Clinic Mgr or Research Leader

Research staff member] Battelle Centers for Public Health Research and Evaluation

Post Clinician Survey-Second Mailing [Flesch-Kincaid Reading Level 12.0]

MCO Letterhead

HFHS or ABQ HP/Lovelace Letterhead

Date

Clinician name

Address 1

Address 2

City State Zip

Dear [Clinician’s name]:

Last year [MCO] and Battelle Centers for Public Health Research began a research study in collaboration with the Centers for Disease Control and Prevention (CDC) to test methods to increase colorectal cancer (CRC) screening. Study results will tell us what works to increase CRC screening, and will help [MCO] and the CDC to improve clinical training and patient education materials concerning CRC screening.

Last month, as part of this study, we requested your participation in a survey to learn more about your opinions and practices regarding colorectal cancer (CRC) screening. We included a payment of $50 as a reimbursement for your valuable time and essential input. Our records indicate that you have not yet returned your completed survey. If you have already completed and returned it, we thank you for your participation. If you have decided to participate and you have not yet completed and returned the survey, please do so now.

Every clinician sampled for this survey has valuable experience and opinions to contribute. Thus, we need the response of every clinician to make this important study valid and influential.

Your responses will be compiled with those of other clinicians in the study, and your responses will be treated private. Your name will not appear with the survey .No individual will be identified in any papers or reports and all study findings will be presented in the aggregate.

Of course, completing this survey is completely voluntary, and you may choose to stop at any time or to answer only some of the questions. If you choose not to complete this survey, this will not have any adverse consequences for you, your practice, or your patients. Some questions about your provision of advice to patients, or about your practices that may differ from institutional clinical practice recommendations may cause you discomfort. The results of this study, however, will provide critical information for the CDC and [MCO] to improve methods to increase CRC screening rates. Your returning this survey provides your consent to participate.

For your convenience, we are enclosing a second copy of the survey and return envelope. Your completed survey should be sent directly to Battelle in the envelope provided.

Please return your survey in the envelope provided.If you have any questions about this research study, please call [Battelle contact] at Battelle, at (206) 528-xxxx or [MCO contact] at [MCO], at (xxx) xxx-xxxx. If you have questions about your rights as a research participant, you may call Battelle’s human subjects supervisor, Margaret Pennybacker, PhD, toll free, at 1-877-810-9530, extension 500. [Insert Appropriate MCO Contact Information and IRB Information, as needed].

We hope you will help us with this important study. Thank you for taking the time to complete this survey.

Sincerely,

MCO contact] Daniel Montaño, PhD

[Clinic Mgr or Research Leader

Research staff member] Battelle Centers for Public Health Research and Evaluation